BridgeMD
New treatment option for Pancreatic Neoplasms
Official title Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
ClinicalTrials.gov ID: NCT06914674
What this study is testing
What is Tamoxifen 20 mg?
Tamoxifen 20 mg is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for pancreatic neoplasms.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Tamoxifen for Solid Pseudopapillary Tumor of the Pancreas
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 80
You may be able to join if
- Age 14-80 years.
- Histologically confirmed advanced SPTP with ER/PR+.
- Advanced disease:
- Unresectable primary tumor or distant metastasis (liver, lung, peritoneum, etc.).
- Recurrent or refractory after prior surgery/systemic therapy.
You likely can't join if
- Non-SPTP pathology.
- Active gastrointestinal inflammation/infection (e.g., pancreatitis).
- Pregnancy/lactation.
- Severe organ dysfunction (renal, cardiac, hepatic, or pulmonary).
- Uncontrolled comorbidities (e.g., CNS disorders, unstable angina).
- Conditions compromising patient safety or data integrity.
See the full eligibility criteria
- Age 14-80 years.
- Histologically confirmed advanced SPTP with ER/PR+.
- Advanced disease:
- Unresectable primary tumor or distant metastasis (liver, lung, peritoneum, etc.).
- Recurrent or refractory after prior surgery/systemic therapy.
- ≥1 measurable lesion.
- ECOG performance status 0-2.
- Life expectancy ≥1 month.
- Able to comply with study visits and oral medication.
- Non-SPTP pathology.
- Active gastrointestinal inflammation/infection (e.g., pancreatitis).
- Pregnancy/lactation.
- Severe organ dysfunction (renal, cardiac, hepatic, or pulmonary).
- Uncontrolled comorbidities (e.g., CNS disorders, unstable angina).
- Conditions compromising patient safety or data integrity.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.